ENDOCYTE INC·4

Mar 2, 2:36 PM ET

Nguyen Binh 4

4 · ENDOCYTE INC · Filed Mar 2, 2012

Insider Transaction Report

Form 4
Period: 2012-02-29
Nguyen Binh
VP of Clinical Affairs
Transactions
  • Award

    Stock Option (right to buy)

    2012-02-29+80,00080,000 total
    Exercise: $3.55Exp: 2022-03-01Common Stock (80,000 underlying)
Footnotes (1)
  • [F1]Shares subject to the option vest 1/4 annually over a period of 4 years beginning on March 1, 2013.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION